Gabriella Gentile

777 total citations
35 papers, 445 citations indexed

About

Gabriella Gentile is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gabriella Gentile has authored 35 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gabriella Gentile's work include Receptor Mechanisms and Signaling (7 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Reproductive Biology and Fertility (4 papers). Gabriella Gentile is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Reproductive Biology and Fertility (4 papers). Gabriella Gentile collaborates with scholars based in Italy, United Kingdom and United States. Gabriella Gentile's co-authors include Marc Laruelle, Roger N. Gunn, Romano Di Fabio, Patrick N. McCormick, Alan A. Wilson, Mustansir Diwan, José N. Nóbrega, Mickaël Huiban, Christophe Plisson and Eugenii A. Rabiner and has published in prestigious journals such as Journal of Clinical Oncology, NeuroImage and Journal of Medicinal Chemistry.

In The Last Decade

Gabriella Gentile

31 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriella Gentile Italy 12 218 166 132 46 35 35 445
Anne Valade Belgium 11 233 1.1× 193 1.2× 88 0.7× 54 1.2× 27 0.8× 19 433
Laurent Provins Belgium 13 190 0.9× 194 1.2× 164 1.2× 32 0.7× 28 0.8× 34 498
Florian Montel Germany 9 153 0.7× 170 1.0× 65 0.5× 62 1.3× 45 1.3× 16 407
François Bischoff Belgium 13 365 1.7× 345 2.1× 170 1.3× 41 0.9× 58 1.7× 22 681
Chunyang Jin United States 14 310 1.4× 173 1.0× 170 1.3× 37 0.8× 29 0.8× 47 579
Adrian J. Carter Germany 11 221 1.0× 203 1.2× 46 0.3× 24 0.5× 37 1.1× 16 425
János Marton Hungary 14 208 1.0× 199 1.2× 117 0.9× 48 1.0× 47 1.3× 37 443
Rebecca A. Roof United States 11 390 1.8× 184 1.1× 76 0.6× 20 0.4× 37 1.1× 19 510
Benjamin R. Chemel United States 9 190 0.9× 247 1.5× 94 0.7× 27 0.6× 34 1.0× 12 408
Anders Bråthe Norway 8 216 1.0× 147 0.9× 118 0.9× 18 0.4× 19 0.5× 9 432

Countries citing papers authored by Gabriella Gentile

Since Specialization
Citations

This map shows the geographic impact of Gabriella Gentile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Gentile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Gentile more than expected).

Fields of papers citing papers by Gabriella Gentile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriella Gentile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Gentile. The network helps show where Gabriella Gentile may publish in the future.

Co-authorship network of co-authors of Gabriella Gentile

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriella Gentile. A scholar is included among the top collaborators of Gabriella Gentile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriella Gentile. Gabriella Gentile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arecco, Luca, Gabriella Gentile, Matteo Lambertini, et al.. (2025). Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives. Current Opinion in Oncology. 37(6). 552–561. 1 indexed citations
2.
Arecco, Luca, et al.. (2025). Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies. Human Reproduction. 40(8). 1452–1466. 2 indexed citations
3.
Gentile, Gabriella, Riccardo Gerosa, Evandro de Azambuja, & Martine Piccart. (2025). 20th anniversary of adjuvant trastuzumab: reflections on a breakthrough moment. Annals of Oncology. 37(4). 470–480.
4.
Gerosa, R., Gabriella Gentile, Luca Arecco, et al.. (2025). Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge. ESMO Open. 10(9). 105758–105758. 1 indexed citations
5.
6.
Gentile, Gabriella, et al.. (2024). Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature. Cancer Treatment Reviews. 128. 102769–102769. 5 indexed citations
7.
Giusti, Raffaele, Marco Filetti, Pasquale Lombardi, et al.. (2023). Out-of-pocket costs burden for cancer treatment toxicities and symptoms management in Italy: A prospective, multicenter pilot study.. Journal of Clinical Oncology. 41(16_suppl). 12105–12105. 1 indexed citations
8.
Gentile, Gabriella, S Caponnetto, Isabella Sperduti, et al.. (2023). Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study. Cancers. 15(13). 3422–3422. 5 indexed citations
9.
Pasquali, Daniela, Luciano Giacomelli, Maria Carmela Pedicillo, et al.. (2023). Tumor Inflammatory Microenvironment of the Thyroid Cancer: Relationship between Regulatory T-Cell Imbalance, and p-NFΚB (p65) Expression—A Preliminary Study. Journal of Clinical Medicine. 12(21). 6817–6817. 5 indexed citations
10.
Giusti, Raffaele, Marco Filetti, Pasquale Lombardi, et al.. (2023). 2087P Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management. Annals of Oncology. 34. S1097–S1097. 1 indexed citations
11.
Cuccu, Ilaria, Gabriella Gentile, Angela Musella, et al.. (2022). Chemo-surgical approach in vulvar leiomyosarcoma: A case report. Tumori Journal. 108(6). NP26–NP29.
12.
Caberlotto, Laura, et al.. (2013). Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(10). 893–903. 14 indexed citations
13.
Gentile, Gabriella, Alfonso Pozzan, Giovanni Bernasconi, et al.. (2012). 5-Aryl-4-carboxamide-1,3-oxazoles: Potent and selective GSK-3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(5). 1989–1994. 39 indexed citations
14.
Arban, Roberto, Federica Bianchi, Alberto Buson, et al.. (2010). Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: Novel, potent, and selective series of Vasopressin1b receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(17). 5044–5049. 34 indexed citations
15.
Passchier, Jan, Gabriella Gentile, Rod A. Porter, et al.. (2010). Identification and evaluation of [11C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography. Synapse. 64(7). 542–549. 27 indexed citations
16.
Holmes, Ian P., Fabrizio Micheli, Olivier Lorthioir, et al.. (2009). Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part one: Lead identification. Bioorganic & Medicinal Chemistry Letters. 19(16). 4799–4801. 9 indexed citations
17.
Micheli, Fabrizio, Ian P. Holmes, Luca Arista, et al.. (2009). Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part two: Lead optimization. Bioorganic & Medicinal Chemistry Letters. 19(15). 4011–4013. 10 indexed citations
18.
Micheli, Fabrizio, Giorgio Bonanomi, Simone Braggio, et al.. (2008). New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems. Bioorganic & Medicinal Chemistry Letters. 18(3). 901–907. 21 indexed citations
19.
Fabio, Romano Di, Giuseppe Alvaro, Barbara Bertani, et al.. (2006). Chiral tetrahydroquinoline derivatives as potent anti-hyperalgesic agents in animal models of sustained inflammation and chronic neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 17(5). 1176–1180. 21 indexed citations
20.
Fabio, Roberto Di, Giovanni Bernasconi, Daniele Donati, et al.. (2005). Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxiety. Bioorganic & Medicinal Chemistry Letters. 15(16). 3713–3716. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Valade Breakdown of academic impact, for papers by Laurent Provins Breakdown of academic impact, for papers by Florian Montel Breakdown of academic impact, for papers by François Bischoff Breakdown of academic impact, for papers by Chunyang Jin Breakdown of academic impact, for papers by Adrian J. Carter Breakdown of academic impact, for papers by János Marton Breakdown of academic impact, for papers by Rebecca A. Roof Breakdown of academic impact, for papers by Benjamin R. Chemel Breakdown of academic impact, for papers by Anders Bråthe
Rankless by CCL
2026